The Kuvan® adult maternal paediatric European registry (KAMPER) multinational observational study: baseline and 1-Year data in phenylketonuria patients responsive to sapropterin

Introduction: Sapropterin dihydrochloride (Kuvan®), a synthetic 6R-diastereoisomer of tetrahydrobiopterin (BH4), is approved in Europe for the treatment of patients aged ≥4 years with hyperphenylalaninaemia (HPA) due to BH4-responsive phenylalanine hydroxylase (PAH) deficiency, in conjunction with a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Trefz, Friedrich K. (VerfasserIn) , Muntau, Ania (VerfasserIn) , Lagler, Florian Bartholomäus (VerfasserIn) , Moreau, Flavie (VerfasserIn) , Alm, Jan (VerfasserIn) , Burlina, Alberto (VerfasserIn) , Rutsch, Frank (VerfasserIn) , Bélanger-Quintana, Amaya (VerfasserIn) , Feillet, François (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 31 March 2015
In: JIMD reports
Year: 2015, Jahrgang: 23, Pages: 35-43
ISSN:2192-8312
DOI:10.1007/8904_2015_425
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/8904_2015_425
Volltext
Verfasserangaben:Friedrich K. Trefz, Ania C. Muntau, Florian B. Lagler, Flavie Moreau, Jan Alm, Alberto Burlina, Frank Rutsch, Amaya Bélanger-Quintana, François Feillet

MARC

LEADER 00000caa a2200000 c 4500
001 1703725905
003 DE-627
005 20220818142126.0
007 cr uuu---uuuuu
008 200706s2015 xx |||||o 00| ||eng c
024 7 |a 10.1007/8904_2015_425  |2 doi 
035 |a (DE-627)1703725905 
035 |a (DE-599)KXP1703725905 
035 |a (OCoLC)1341344681 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Trefz, Friedrich K.  |d 1945-  |e VerfasserIn  |0 (DE-588)130846341  |0 (DE-627)506362019  |0 (DE-576)298373289  |4 aut 
245 1 4 |a The Kuvan® adult maternal paediatric European registry (KAMPER) multinational observational study  |b baseline and 1-Year data in phenylketonuria patients responsive to sapropterin  |c Friedrich K. Trefz, Ania C. Muntau, Florian B. Lagler, Flavie Moreau, Jan Alm, Alberto Burlina, Frank Rutsch, Amaya Bélanger-Quintana, François Feillet 
264 1 |c 31 March 2015 
300 |a 9 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 06.07.2020 
520 |a Introduction: Sapropterin dihydrochloride (Kuvan®), a synthetic 6R-diastereoisomer of tetrahydrobiopterin (BH4), is approved in Europe for the treatment of patients aged ≥4 years with hyperphenylalaninaemia (HPA) due to BH4-responsive phenylalanine hydroxylase (PAH) deficiency, in conjunction with a phenylalanine-restricted diet, and also for the treatment of patients with BH4 deficiency. Aims/methods: KAMPER is an ongoing, observational, multicentre registry with the primary objective of providing information over 15 years on long-term safety of sapropterin dihydrochloride treatment in patients with HPA. Here we report initial data on characteristics from patients recruited by the time of the third interim analysis and results at 1 year. Results: Overall, 325 patients from 55 sites in seven European countries were included in the analysis: 296 (91.1%) patients with PAH deficiency (median [Q1, Q3] age, 10.3 [7.2, 15.0] years) and 29 (8.9%) with BH4 deficiency (12.8 [6.6, 18.9] years). Fifty-nine patients (18.2%) were aged ≥18 years; 4 patients were pregnant. No elderly patients (aged ≥65 years) or patients with renal or hepatic insufficiency were enroled in the study. Twelve-month data were available for 164 patients with PAH deficiency and 16 with BH4 deficiency. No new safety concerns were identified as of May 2013. Conclusions: Initial data from KAMPER show that sapropterin dihydrochloride has a favourable safety profile. Registry data collected over time will provide insight into the management and outcomes of patients with PAH deficiency and BH4 deficiency, including long-term safety, impact on growth and neurocognitive outcomes and the effect of sapropterin dihydrochloride treatment on populations of special interest. 
650 4 |a BH4-responsive phenylketonuria 
650 4 |a Hyperphenylalaninaemia 
650 4 |a Phenylketonuria 
650 4 |a Sapropterin 
650 4 |a Tetrahydrobiopterin deficiency 
700 1 |a Muntau, Ania  |d 1965-  |e VerfasserIn  |0 (DE-588)128520094  |0 (DE-627)37420294X  |0 (DE-576)170651339  |4 aut 
700 1 |a Lagler, Florian Bartholomäus  |d 1972-  |e VerfasserIn  |0 (DE-588)124004210  |0 (DE-627)085577855  |0 (DE-576)293977623  |4 aut 
700 1 |a Moreau, Flavie  |e VerfasserIn  |4 aut 
700 1 |a Alm, Jan  |e VerfasserIn  |4 aut 
700 1 |a Burlina, Alberto  |e VerfasserIn  |0 (DE-588)1237465575  |0 (DE-627)1764177592  |4 aut 
700 1 |a Rutsch, Frank  |e VerfasserIn  |0 (DE-588)1203255721  |0 (DE-627)1688060324  |4 aut 
700 1 |a Bélanger-Quintana, Amaya  |e VerfasserIn  |4 aut 
700 1 |a Feillet, François  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t JIMD reports  |d Hoboken, NJ : Wiley, 2011  |g 23(2015), Seite 35-43  |h Online-Ressource  |w (DE-627)719754178  |w (DE-600)2672872-2  |w (DE-576)433490195  |x 2192-8312  |7 nnas  |a The Kuvan® adult maternal paediatric European registry (KAMPER) multinational observational study baseline and 1-Year data in phenylketonuria patients responsive to sapropterin 
773 1 8 |g volume:23  |g year:2015  |g pages:35-43  |g extent:9  |a The Kuvan® adult maternal paediatric European registry (KAMPER) multinational observational study baseline and 1-Year data in phenylketonuria patients responsive to sapropterin 
856 4 0 |u https://doi.org/10.1007/8904_2015_425  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20200706 
993 |a Article 
994 |a 2015 
998 |g 130846341  |a Trefz, Friedrich K.  |m 130846341:Trefz, Friedrich K.  |d 910000  |d 910500  |e 910000PT130846341  |e 910500PT130846341  |k 0/910000/  |k 1/910000/910500/  |p 1  |x j 
999 |a KXP-PPN1703725905  |e 3695741147 
BIB |a Y 
SER |a journal 
JSO |a {"language":["eng"],"note":["Gesehen am 06.07.2020"],"relHost":[{"language":["eng"],"disp":"The Kuvan® adult maternal paediatric European registry (KAMPER) multinational observational study baseline and 1-Year data in phenylketonuria patients responsive to sapropterinJIMD reports","physDesc":[{"extent":"Online-Ressource"}],"note":["Erscheint viermal jährlich","Gesehen am 09.04.2021","Fortsetzung der Druck-Ausgabe"],"origin":[{"dateIssuedKey":"2011","dateIssuedDisp":"2011-","publisher":"Wiley ; Springer","publisherPlace":"Hoboken, NJ ; Berlin ; Heidelberg"}],"title":[{"title_sort":"JIMD reports","title":"JIMD reports"}],"titleAlt":[{"title":"JIMD Rep"},{"title":"Case and research reports"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"part":{"year":"2015","pages":"35-43","volume":"23","extent":"9","text":"23(2015), Seite 35-43"},"name":{"displayForm":["SSIEM"]},"pubHistory":["1.2011 -"],"id":{"zdb":["2672872-2"],"eki":["719754178"],"issn":["2192-8312"]},"recId":"719754178"}],"physDesc":[{"extent":"9 S."}],"origin":[{"dateIssuedDisp":"31 March 2015","dateIssuedKey":"2015"}],"title":[{"subtitle":"baseline and 1-Year data in phenylketonuria patients responsive to sapropterin","title":"The Kuvan® adult maternal paediatric European registry (KAMPER) multinational observational study","title_sort":"Kuvan® adult maternal paediatric European registry (KAMPER) multinational observational study"}],"person":[{"role":"aut","family":"Trefz","display":"Trefz, Friedrich K.","roleDisplay":"VerfasserIn","given":"Friedrich K."},{"family":"Muntau","roleDisplay":"VerfasserIn","display":"Muntau, Ania","given":"Ania","role":"aut"},{"role":"aut","family":"Lagler","given":"Florian Bartholomäus","roleDisplay":"VerfasserIn","display":"Lagler, Florian Bartholomäus"},{"role":"aut","family":"Moreau","given":"Flavie","roleDisplay":"VerfasserIn","display":"Moreau, Flavie"},{"role":"aut","family":"Alm","roleDisplay":"VerfasserIn","display":"Alm, Jan","given":"Jan"},{"roleDisplay":"VerfasserIn","display":"Burlina, Alberto","given":"Alberto","family":"Burlina","role":"aut"},{"family":"Rutsch","given":"Frank","roleDisplay":"VerfasserIn","display":"Rutsch, Frank","role":"aut"},{"family":"Bélanger-Quintana","display":"Bélanger-Quintana, Amaya","roleDisplay":"VerfasserIn","given":"Amaya","role":"aut"},{"given":"François","roleDisplay":"VerfasserIn","display":"Feillet, François","family":"Feillet","role":"aut"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"name":{"displayForm":["Friedrich K. Trefz, Ania C. Muntau, Florian B. Lagler, Flavie Moreau, Jan Alm, Alberto Burlina, Frank Rutsch, Amaya Bélanger-Quintana, François Feillet"]},"recId":"1703725905","id":{"eki":["1703725905"],"doi":["10.1007/8904_2015_425"]}} 
SRT |a TREFZFRIEDKUVANADULT3120